-
Intensive lipid lowering with statin therapy (atorvastatin 80 mg) in patients presenting with acute coronary syndromes (ACS) resulted in improved outcomes compared to treatment with moderate lipid lowering (pravastatin 40 mg) in the PROVE-IT TIMI-22 study (Cannon et al. N Engl J Med. 2004;350:1495-1504), which included patients treated conservatively, as well as those treated with percutaneous coronary intervention (PCI).
-
Congestive heart failure (CHF) is the most common DRG for Medicare patients in U.S. hospitals and is therefore the target of considerable regulatory attention due to its financial impact on the federal budget.
-
Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions
-
-
-
Immunomodulatory therapy reduces the rate of conversion to generalized myasthenia gravis in seniors with pure ocular myasthenia.
-
Neuropathy occurs with a high frequency in patients with end-stage liver disease, but rarely causes disability.
-
Fixed dose of IVIg may not be effective in all patients with GBS.
-
Two studies have identified a novel inclusion found in a subset of FTLD brains and categorize the clinical entity of the behavioral variant of FTLD, based on anatomical patterns.
-
